Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors with targeted therapies von Atkins, Michael B, Ascierto, Paolo A, Feltquate, David, Gulley, James L, Johnson, Douglas B, Khushalani, Nikhil I, Sosman, Jeffrey, Yap, Timonthy A, Kluger, Harriet, Sullivan, Ryan J, Tawbi, Hussein

Volltext

Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory von Mendoza, Tito, Sheshadri, Ajay, Altan, Mehmet, Hess, Kenneth, George, Goldy, Stephen, Bettzy, Castillo, Lilibeth, Rodriguez, Enedelia, Gong, Jing, Peterson, Christine, Rodon Ahnert, Jordi, Fu, Siqing, Piha-Paul, Sarina A, Pant, Shubham, Dumbrava, Ecaterina, Yap, Timonthy A, Janku, Filip, Tsimberidou, Apostolia M, Subbiah, Vivek, Karp, Daniel D, Zarifa, Abdulrazzak, McQuinn, Lacey M, Cleeland, Charles, Hong, David S, Naing, Aung

Volltext

Preclinical study and parallel phase II trial evaluating antisense STAT3 oligonucleotide and checkpoint blockade for advanced pancreatic, non-small cell lung cancer and mismatch re... von Tang, Chad, Hartley, Genevieve P, Couillault, Coline, Yuan, Ying, Lin, Heather, Nicholas, Courtney, Srinivasamani, Anupallavi, Dai, James, Dumbrava, Ecaterina E Ileana, Fu, Siqing, Karp, Daniel D, Naing, Aung, Piha-Paul, Sarina A, Rodon Ahnert, Jordi, Pant, Shubham, Subbiah, Vivek, Yap, Timonthy A, Tsimberidou, Apostolia M, Guerrero, Paola, Dhebat, Sarah, Proia, Theresa, Curran, Michael A, Hong, David S

Volltext